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A mortality survey conducted by the World Health Organisation and the Sudanese Ministry of Health concluded that between mid-June
and mid-August 2004 up to 3 people per 10,000 died every day in some regions of Darfur (www.who.int/en). This is three times
that expected during a humanitarian crisis. An estimated 1.2 million people in Darfur have fled from their villages and are now living
in 129 Internally Displaced Persons (IDP) camps over an area the size of France. Many of the medical problems they are suffering from are
theoretically preventable and treatable. The leading cause of death according to the WHO survey is dysentery, and between 50 and 75%
of deaths of children under five are due to diarrhoea. It is proving difficult to maintain basic levels of hygiene in the camps, with
problems such as overcrowding, unsafe water supplies, inadequate latrines, lack of soap and recent heavy rains. Of concern, 15% of
all deaths were due to injuries and violence, although no details of the nature of the violence were given in the report.
Hepatitis E in Darfur
The WHO reported a total of 3753 cases and 55 deaths from suspected hepatitis E between 22 May and 27 August 2004, through the early
warning alert and response system (EWARN) (ProMED mail archive number 20040908.2506). Seventy three percent of all reported cases
were from West Darfur. The incidence was particularly high in the Morni IDP camp, and as expected most of the deaths were in pregnant
women. If fulminant hepatitis develops in the third trimester of pregnancy, it carries a mortality of 20%.
Compared to previous reports, there was a slight fall in cases reported from South and West Darfur, and a slight increase from North
Darfur (ProMED mail archive number 20040908.2506). The diagnosis has been confirmed in some cases by ELISA and PCR carried out by
the Naval Medical Research Unit in Cairo, Egypt.
The epidemiology of Hepatitis E virus (HEV) has been discussed previously (ProMED update, IJID 2002; 6: 245). The outbreak in Darfur is
undoubtedly due to inadequate and unsafe water supplies and poor sanitary conditions. Existing resources are not enough to meet the
basic water and sanitation needs of the camps. Many organizations are striving to improve the quality and quantity of the water supply,
by simple public health measures such as health promotion activities, safe handling of food, safe disposal of sewage, distribution of soap
and construction of latrines. Pregnant women and other high risk groups are being targeted through community education programmes.
Recent epidemics of HEV have been reported in Central and South-East Asia, North and West Africa, and Mexico. Cases were associated
with faecal contamination of drinking water. In addition, sporadic cases have been reported worldwide, and serological surveys suggest
a global distribution of less pathogenic strains of HEV which cause asymptomatic or mild disease (ProMED mail archive number
20040827.2399).
Hepatitis E in Sudanese Refugee camps in Chad
Sudanese people from Darfur who have fled to refugee camps based at Goz Amer, Goz Abal, and neighbouring villages in Eastern Chad
(which borders Sudan) have also been affected by HEV. On 15 September, the WHO reported that 42 people, mostly pregnant women, died
out of 1292 probable cases of HEV between 26 June and 12 September 2004 (ProMED mail archive number 20040915.2570). It appears that
the overall weekly number of reported cases is falling, but very slowly. Although the number of cases is higher in Sudan, information
available to date suggests that the mortality in Chad is 3.3% compared to 1.5% in Sudan. Reasons for this are not yet clear.
Preliminary investigations in Goz Amer suggested that the location of water points and latrines were suboptimal and chlorination
methods ineffective. The WHO, United Nations High Commissioner for Refugees (UNHCR), and various nongovernmental organizations
are supporting the Ministry of Health in implementing control measures and improving disease surveillance.E-mail addresses: fiona.cooke@ic.ac.uk (F.J. Cooke), dan@promedmail.org (D.S. Shapiro)
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The EWARN early warning system detected an outbreak of Shigellosis at the end of June 2004 in the Abu Shoak IDP camp, North Darfur.
There were about 40,000 people in the camp at this time. 1340 cases of bloody diarrhoea with 11 deaths had been reported by the end of
June. The outbreak probably started in the middle of May 2004. Three of 13 stool samples tested were positive for Shigella dysenteriae
type 1 (ProMED mail archive number 20040716.1927).
Cholera in Western Chad and Niger
In Western Chad, more than 120 people have died from cholera in an epidemic which started in mid-June 2004 (ProMED mail archive
number 20040910.2520). By the beginning of September there were almost 3000 cases. The source of the outbreak is thought to have
been a small fishing village on the shores of Lake Chad. There has been a smaller epidemic in three regions of Niger, where there were
almost 1600 reported cases and 32 people died. This epidemic was also first reported from a fishing port in the Lake Chad basin (ProMED
mail archive number 20040910.2520). Cholera epidemics perennially hit Niger, especially along the Niger river, which is the main source
of drinking water for most of the population. No cholera cases have been reported so far from the refugee camps in Eastern Chad, but
this population are at high risk of the infection considering the problems with overcrowding and sanitation discussed above.
Melioidosis in Singapore
Melioidosis has killed 24 of the 79 people (30%) infected in Singapore as of September 16, 2004, a three-fold rise in the death rate for the
disease as compared with 10% (4 of 40 infected individuals) during 2003 (ProMED mail archive number 20040917.2578). An investigation
in which isolates of Burkholderia pseudomallei from different patients were compared, reportedly showed that the isolates were of a
number of different strains, makes a bioterrorism incident highly unlikely.
The specific increase in the mortality rate this year remains under investigation. Epidemiologically, 80% of those who died had existing
health problems, such as diabetes and more than 75% of the victims were over age 45.
Yellow fever vaccine-associated viscerotropic disease and history of thymoma
The live vaccines that have been used to prevent yellow fever have had a superb safety record, but in recent years there have been
9 cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) in the United States and an additional 14 cases worldwide,
as reported in the September 11, 2004 issue of The Lancet by the Yellow Fever Vaccine Safety Working Group (available free at http://
pdf.thelancet.com/pdfdownload?uid=llan.364.9438.analysis_and_interpretation.30682.1&x=x.pdf). 14 (61%) of the cases have been
fatal.
An evaluation of the potential risk factors for YEL-AV has found that four (17%) of the 23 vaccinees reported with this syndrome had a
history of thymic disease and had undergone thymectomy for either malignant or benign disease, suggesting that thymic dysfunction is
an independent risk factor for YEL-AVD.
